Gene:
ALDH1A1
aldehyde dehydrogenase 1 family, member A1

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no clinical annotations for this gene. To report clinical variants, click here.

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

Variant?
(build 132)
Alternate Names ? Drugs ? Alleles ?
(+ chr strand)
Function ? Amino Acid?
Translation
rs6151031 ALDH1A1*2, g.4586_4587ins17, g.4732915_4732916ins17
- > CTGGTGAGGAGAGAACC
Not Available
VIP No Clinical Annotations available No Variant Annotations available
rs72554629 ALDH1A1*3, g.4492_4493ins3, g.4733009_4733010ins3
- > GTA
- > TAC
Not Available
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP build 132

Overview

Alternate Names:  ALDH class 1; ALHDII; RALDH 1; acetaldehyde dehydrogenase 1; aldehyde dehydrogenase 1, soluble; aldehyde dehydrogenase 1A1; aldehyde dehydrogenase family 1 member A1; aldehyde dehydrogenase, cytosolic; aldehyde dehydrogenase, liver cytosolic; retinal dehydrogenase 1; retinaldehyde dehydrogenase 1
Alternate Symbols:  ALDC; ALDH-E1; ALDH1; ALDH11; ALDH1A1-PENDING; MGC2318; PUMB1; RALDH1
PharmGKB Accession Id: PA24692

Details

Cytogenetic Location: chr9 : q21.13 - q21.13
GP mRNA Boundary: chr9 : 75515587 - 75567969
GP Gene Boundary: chr9 : 75512587 - 75577969
Strand: minus
Product Name: No data available
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

  1. Cyclophosphamide Pathway, Pharmacodynamics
    Model non-tissue-specific cancer cell displaying genes which may be involved in the cyclophosphamide pathway.
  1. Ifosfamide Pathway (PD)
    Model non-tissue specific cancer cell displaying genes which may be involved in the ifosfamide pathway

External Pathways

Links to non-PharmGKB pathways.

  1. Acetaldehyde is oxidized by NAD+ to form acetate, NADH, and H+ - (Reactome via Pathway Interaction Database)
No related genes are available

Curated Information ?

Curated Information ?

Publications related to ALDH1A1: 9

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature. Pharmacogenetics and genomics. 2009. Black William J, et al. [Article:19823103@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide. Pharmacogenetics and genomics. 2008. Ekhart Corine, et al. [Article:18496131@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin. Pharmacogenetics and genomics. 2008. Ekhart Corine, et al. [Article:18854779@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism. 2007. Edenberg Howard J. [Article:17718394@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug metabolism reviews. 2004. Vasiliou Vasilis, et al. [Article:15237855@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acid. The Journal of biological chemistry. 2003. Molotkov Andrei, et al. [Article:12851412@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Molecular pharmacology. 2002. Maglich Jodi M, et al. [Article:12181440@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. European journal of biochemistry / FEBS. 2000. Duester G. [Article:10880953@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. Pharmacology. 2000. Vasiliou V, et al. [Article:10971205@PubMed]

LinkOuts

Entrez Gene:
216
OMIM:
100640
UCSC Genome Browser:
NM_000689
RefSeq RNA:
NM_000689
RefSeq Protein:
NP_000680
RefSeq DNA:
AC_000052
AC_000141
NC_000009
NG_012249
NT_008470
NW_001839221
NW_924484
UniProtKB:
AL1A1_HUMAN (P00352)
Ensembl:
ENSG00000165092
GenAtlas:
ALDH1A1
GeneCard:
GC09M075515 (216)
MutDB:
ALDH1A1
ALFRED:
LO004070L
HuGE:
ALDH1A1
Comparative Toxicogenomics Database:
216
ModBase:
P00352
HumanCyc Gene:
HS09183
HGNC:
402

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.